What is the recommended treatment and follow‑up for an HIV‑positive patient with a positive rapid plasma reagin (RPR) test and confirmed Treponema pallidum infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Follow-Up for HIV-Positive Patient with Confirmed Syphilis

Immediate Treatment Recommendation

Treat with benzathine penicillin G 2.4 million units intramuscularly as a single dose for early syphilis (primary, secondary, or early latent), or three weekly doses of 2.4 million units IM for late latent or unknown duration syphilis. 1

Determining Disease Stage

Before initiating treatment, you must establish the stage of syphilis:

  • Early syphilis (primary, secondary, or early latent ≤1 year) is defined by documented seroconversion within the past year, symptoms of primary/secondary syphilis within the past year, or a sexual partner with confirmed early syphilis 1

  • Late latent syphilis (>1 year or unknown duration) applies when infection timing cannot be established or exceeds one year 1

  • Evaluate for neurosyphilis before treatment if the patient has neurologic symptoms (cognitive dysfunction, motor/sensory deficits, cranial nerve palsies, meningismus), ocular symptoms (uveitis, vision changes), auditory symptoms, or a nontreponemal titer ≥1:32 with late latent disease 1, 2

Treatment Regimens by Stage

Early Syphilis (Primary, Secondary, or Early Latent)

  • Benzathine penicillin G 2.4 million units IM as a single dose 1, 2

  • HIV-infected patients receive the same single-dose regimen as HIV-negative patients—multiple doses do not improve outcomes 1, 3

  • Do not use enhanced regimens (additional penicillin doses, amoxicillin plus probenecid) as they provide no additional benefit 1

Late Latent or Unknown Duration Syphilis

  • Benzathine penicillin G 2.4 million units IM weekly for three consecutive weeks (total 7.2 million units) 1, 2

  • Consider CSF examination before treatment in HIV-infected patients with late latent syphilis to exclude neurosyphilis, particularly if CD4 count ≤350 cells/mL or RPR titer ≥1:32 1, 2

Neurosyphilis

  • Aqueous crystalline penicillin G 18–24 million units per day IV (administered as 3–4 million units every 4 hours or continuous infusion) for 10–14 days 1, 2

  • Alternative: Procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily for 10–14 days (probenecid is mandatory to achieve adequate CSF levels) 1, 2

  • Some experts add benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing the neurosyphilis regimen to provide comparable total duration 1, 2

Penicillin Allergy Management

  • Penicillin desensitization is strongly preferred for HIV-infected patients with penicillin allergy, followed by standard penicillin therapy 1, 2

  • If desensitization is not feasible for early syphilis: doxycycline 100 mg orally twice daily for 14 days (with close clinical and serologic monitoring) 1, 2

  • If desensitization is not feasible for late latent syphilis: doxycycline 100 mg orally twice daily for 28 days, but only after CSF examination excludes neurosyphilis 1, 2

  • Avoid azithromycin due to widespread macrolide resistance and documented treatment failures 1, 2

  • Ceftriaxone 1 gram IM/IV daily for 10–14 days may be considered for early syphilis, but data in HIV-infected patients are limited 1, 2, 4

HIV-Specific Follow-Up Schedule

HIV-infected patients require more intensive monitoring than HIV-negative patients:

  • Clinical and serologic evaluation at 3,6,9,12, and 24 months after treatment 1, 2

  • Repeat quantitative RPR (or VDRL) at each visit using the same laboratory and same test method to ensure comparability 1, 2

  • Treatment success is defined as a fourfold (two-dilution) decline in nontreponemal titers 1, 2

  • For early syphilis, expect a fourfold decline within 3–6 months; for late latent syphilis, expect this decline within 12–24 months 1, 2

Treatment Failure Criteria

Retreatment and CSF examination are indicated if:

  • Nontreponemal titers fail to decline fourfold within the expected timeframe (3 months for primary/secondary syphilis, 12–24 months for late latent) 1, 2

  • Nontreponemal titers increase fourfold (two dilutions) at any time after treatment 1, 2

  • New or persistent clinical signs or symptoms develop 1, 2

Management of Treatment Failure

  • Perform CSF examination to evaluate for neurosyphilis 1, 2

  • If CSF is normal, retreat with benzathine penicillin G 7.2 million units (three weekly doses of 2.4 million units IM) 1, 2

  • If CSF shows neurosyphilis, treat with the neurosyphilis regimen (IV aqueous crystalline penicillin G) 1, 2

Critical Considerations for HIV-Infected Patients

  • HIV-infected patients may have atypical serologic responses (unusually high, low, or fluctuating titers), but this does not change treatment regimens 1, 2, 5

  • Despite concerns about altered responses, standard benzathine penicillin regimens are effective in HIV-infected patients 1, 5, 3

  • A randomized trial demonstrated that single-dose benzathine penicillin is as effective as three doses for early syphilis in HIV-infected patients (93% vs 100% success rate, not statistically different) 3

  • However, closer follow-up is mandatory because HIV-infected patients have higher rates of treatment failure and disease progression 1, 2

  • Some studies suggest HIV-infected patients with primary syphilis may be less likely to achieve fourfold RPR decline within 6 months compared to HIV-negative patients, but those with secondary syphilis have similar responses 6

Common Pitfalls to Avoid

  • Do not use multiple doses of benzathine penicillin for early syphilis in HIV-infected patients—evidence shows no benefit 1, 3

  • Do not skip CSF examination in HIV-infected patients with late latent syphilis, especially if CD4 ≤350 cells/mL or RPR ≥1:32 1, 2

  • Do not use procaine penicillin without probenecid for neurosyphilis—it will not achieve adequate CSF levels 1, 2

  • Do not switch between RPR and VDRL when monitoring response—titers are not directly comparable 1, 2

  • Do not assume treatment failure based solely on persistent low titers (≤1:4)—15–25% of successfully treated patients remain "serofast" 2, 7

  • Do not use oral penicillin preparations for any stage of syphilis—they are ineffective 2, 4

Additional Recommendations

  • Test all syphilis patients for HIV if status is unknown 1, 2

  • Warn patients about Jarisch-Herxheimer reaction—an acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment, especially in early syphilis 1, 2, 4

  • Presumptively treat sexual partners exposed within 90 days before diagnosis, even if seronegative 1, 2, 4

  • Screen for other sexually transmitted infections (gonorrhea, chlamydia) at the time of syphilis diagnosis 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Research

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

4
Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

7
Guideline

Management of Syphilis with Low RPR Titers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate treatment for a patient with late latent syphilis, as indicated by positive RPR and TPHA results without evidence of neurosyphilis?
What is the most appropriate treatment for a patient with early-stage syphilis (infection with Treponema pallidum) presenting with a painless, indurated sore on the penis?
What are the expected syphilis serology results, specifically Enzyme Immunoassay (EIA) and Rapid Plasma Reagin (RPR) titer, for a patient who has completed successful treatment for early-latent syphilis and has not had any subsequent sexual encounters?
What is the recommended treatment for a 41-year-old male with a syphilis titer of 1:64, asymptomatic, and a history of syphilis and male-to-male intercourse?
What is the treatment for a 75-year-old female with a positive Rapid Plasma Reagin (RPR) test, no history of previous treatment, and normal kidney and liver function?
How does serum bilirubin level indicate severity in chronic liver disease?
What is the appropriate acute and preventive treatment for a patient with typical episodic or chronic cluster headache?
In a type 2 diabetic patient on metformin with eGFR ≥45 mL/min/1.73 m², can dapagliflozin be taken in the morning and sitagliptin later in the day?
In a stable adult without active bleeding or cardiac disease, should a hemoglobin of 9.8 g/dL (hematocrit 27.5%) be transfused?
In a stable adult patient with no active bleeding, no cardiac disease, asymptomatic, and a hematocrit of 27.5% (hemoglobin 9.8 g/dL), is red‑cell transfusion indicated?
For an adult patient scheduled for elective surgery tomorrow under spinal anaesthesia, should ACE inhibitor/ARB and diuretic be held on the day of surgery to avoid peri‑operative hypotension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question